Abiopharma

New Form 8-K - Catheter Precision, Inc. Filed: 2025-06-13 AccNo: 0001437749-25-020251 Size: 200 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 40-17F2 - DAXOR CORP Filed: 2025-06-13 AccNo: 0001641172-25-014960 Size: 73 KB

Waiver: Grant of Extension of Time in Relation to Rule 704(7) of the Catalist Rules

New Form 8-K - Inspire Medical Systems, Inc. Filed: 2025-06-13 AccNo: 0001609550-25-000025 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 424B5 - Enliven Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0001193125-25-140298 Size: 713 KB

New Form D - TuHURA Biosciences, Inc./NV Filed: 2025-06-13 AccNo: 0000950123-25-006026 Size: 13 KB

New Form 8-K - Incannex Healthcare Inc. Filed: 2025-06-13 AccNo: 0001213900-25-053995 Size: 196 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

New Form 4 - Lantern Pharma Inc. Filed: 2025-06-13 AccNo: 0001104659-25-059106 Size: 49 KB

New Form 8-K - Enliven Therapeutics, Inc. Filed: 2025-06-13 AccNo: 0001193125-25-140285 Size: 217 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - Lantern Pharma Inc. Filed: 2025-06-13 AccNo: 0001104659-25-059091 Size: 38 KB